ESENTRA 120MG INJECTION 1.7 ML

ESENTRA 120MG INJECTION 1.7 ML is not recommended in patients with a history of certain cancers, such as multiple myeloma or bone metastases. It is important to discuss your medical history and any previous or current cancer diagnoses with your healthcare provider before starting this medication.

ESENTRA 120MG INJECTION 1.7 ML is primarily eliminated through the kidneys, so caution is advised in patients with severe renal impairment or end-stage renal disease. Your healthcare provider will assess the potential risks and benefits based on your renal function.

Yes, ESENTRA 120MG INJECTION 1.7 ML is approved for the treatment of osteoporosis in men at increased risk of fractures. It can help improve bone density and reduce fracture risk in male patients with osteoporosis.

ESENTRA 120MG INJECTION 1.7 ML is not approved for use in children and adolescents with osteoporosis. The safety and efficacy of this medication have not been established in this population.

ESENTRA 120MG INJECTION 1.7 ML use has been associated with a slightly increased risk of jaw osteonecrosis (ONJ). Suppose you have dental implants or are considering getting them. In that case, it is important to discuss this with your dentist and healthcare provider to assess ESENTRA 120MG INJECTION 1.7 ML's potential risks and benefits.

ESENTRA 120MG INJECTION 1.7 ML can cause side effects like injection site reactions, back and musculoskeletal pain, infections, abdominal pain, headache, and low blood phosphate levels. Rare but serious side effects may include osteonecrosis of the jaw, atypical femoral fractures, hypocalcemia, and severe skin reactions.

ESENTRA 120MG INJECTION 1.7 ML can interact with other drugs. It is important to inform your doctor about all medications you are taking. Also, avoid taking any vaccines during treatment with ESENTRA 120MG INJECTION 1.7 ML.

While taking ESENTRA 120MG INJECTION 1.7 ML, attend all scheduled appointments. Inform your doctor about your medical history, including infections, liver disease, and kidney disease, and any allergies. Seek medical attention for severe allergic reactions or serious side effects. Monitor calcium levels and ensure adequate calcium and vitamin D intake. Avoid vaccines during treatment. Maintain good oral hygiene and have regular dental check-ups. Pregnant and breastfeeding women should consult a doctor.

The active molecule used in making ESENTRA 120MG INJECTION 1.7 ML is DENOSUMAB.

Yes, ESENTRA 120MG INJECTION 1.7 ML is prescribed for the treatment of Osteoporosis.

Yes, ESENTRA 120MG INJECTION 1.7 ML can be prescribed for Arthritis. Consult your doctor for specific use.